The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | Molecular testing in the UK
John Bridgewater, BA, MBBS, MRCP, PhD, University College London Hospitals NHS Foundation Trust, London, UK, discusses advances and logisitics of molecular testing in the UK. He discusses the molecular testing required for patients with cholangiocarcinoma for fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement, prior to treatment with pemigatinib. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
Disclosures
Prof. Bridgewater reports advisory capacity to Incyte.
